Helio Genomics, a leading AI-powered TechBio company focused on revolutionizing early cancer detection, today announced a strategic commercial partnership with Syneos Health®, a leading fully ...

A study led by Dr. Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore), has ...

The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

A protein doctors routinely use to measure how aggressively tumors are growing may also help prevent the chromosome errors ...

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...

Single-cell analysis reveals the extent of genome doubling in ovarian cancer, its variability and its role in enabling tumours to evade the immune system. Read the paper: Ongoing genome doubling ...

Ultima Genomics today announced Francisco De La Vega, DSc, has joined the Company as Vice President, Germline Genomics & Distinguished Scientific Fellow. With over 25 years of leadership experience in ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...